SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-197039
Filing Date
2024-08-08
Accepted
2024-08-08 16:47:32
Documents
7
Effectiveness Date
2024-08-08

Document Format Files

Seq Description Document Type Size
1 S-8 d881724ds8.htm S-8 46946
2 EX-5.1 d881724dex51.htm EX-5.1 11180
3 EX-23.2 d881724dex232.htm EX-23.2 2075
4 EX-99.1(A) d881724dex991a.htm EX-99.1(A) 148626
5 EX-FILING FEES d881724dexfilingfees.htm EX-FILING FEES 16866
6 GRAPHIC g881724dsp6.jpg GRAPHIC 3954
7 GRAPHIC g881724dsp7.jpg GRAPHIC 1976
  Complete submission text file 0001193125-24-197039.txt   235376
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-281394 | Film No.: 241189237
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)